StockData
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. (SLGL) stock

SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$55.12−1.13 (-2.01%)

Close on Nov 13, 2026Market cap $153.57MP/E –Yield –

Sol-Gel Technologies cash

Cash and short-term investments held at the end of each period.

Sol-Gel Technologies's cash was $47.93M at Jun 30, 2026. For fiscal 2025 it was $24.00M, down 4.3% from the year before. Over ten years it grew 15.1% a year on average. The highest annual figure on record is $62.34M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.00M-4.3%
FY2024Dec 31, 2024$25.09M-10.3%
FY2023Dec 31, 2023$27.98M+25.6%
FY2022Dec 31, 2022$22.28M-2.9%
FY2021Dec 31, 2021$22.94M-23.3%
FY2020Dec 31, 2020$29.92M-41.0%
FY2019Dec 31, 2019$50.73M-18.6%
FY2018Dec 31, 2018$62.34M+1140.8%
FY2017Dec 31, 2017$5.02M-28.2%
FY2016Dec 31, 2016$7.00M+18.8%
FY2015Dec 31, 2015$5.90M+892.4%
FY2014Dec 31, 2014$594.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$47.93M+81.1%
Q4 FY2025Dec 31, 2025$24.00M-14.2%
Q2 FY2025Jun 30, 2025$24.28M-27.5%
Q4 FY2024Dec 31, 2024$25.09M+12.6%
Q2 FY2024Jun 30, 2024$26.46M+69.5%
Q4 FY2023Dec 31, 2023$27.98M+22.0%
Q2 FY2023Jun 30, 2023$33.48M+86.2%
Q4 FY2022Dec 31, 2022$22.28M-25.6%
Q2 FY2022Jun 30, 2022$15.61M-66.2%
Q4 FY2021Dec 31, 2021$22.94M-54.8%
Q2 FY2021Jun 30, 2021$17.98M-64.0%
Q4 FY2020Dec 31, 2020$29.92M-52.0%
Q2 FY2020Jun 30, 2020$46.12M+152.9%
Q4 FY2019Dec 31, 2019$50.73M+909.7%
Q2 FY2019Jun 30, 2019$49.91M+612.9%
Q4 FY2018Dec 31, 2018$62.34M+957.5%
Q2 FY2018Jun 30, 2018$18.24M+2970.7%
Q4 FY2017Dec 31, 2017$5.02M–
Q4 FY2016Dec 31, 2016$7.00M–
Q4 FY2015Dec 31, 2015$5.90M–
Q4 FY2014Dec 31, 2014$594.00K–

More Sol-Gel Technologies figures

See a number that looks wrong?